Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Systemic corticosteroids may effectively treat follicular mucinosis.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Blocking interferon-gamma might help treat various autoimmune diseases.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Inflammation may play a role in causing androgenetic alopecia.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Some drugs for inflammation may cause psoriasis-like hair loss.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Allopurinol may cause rare granulomatous microscopic colitis.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

No established treatment effectively stops inflammation and prevents hair loss in folliculitis decalvans.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Alopecic and aseptic nodules of the scalp are rare, treatable, and often resolve with doxycycline or on their own.

The document reports the first case of a rare skin condition in Colombia, the 19th case worldwide.

Patients need better information about the risks of long-term steroid use.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

The rash worsened due to a fungal infection masked by corticosteroids.

Certain inflammatory factors may increase or decrease the risk of developing PCOS.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

The patient's scalp lesions stabilized with a combination of treatments after initial therapies failed.